Elite in Type 2 Diabetes (T2D)

Dr. Guillermo E. Umpierrez

Endocrinology
Emory Medical Care Foundation Inc
80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
Offers Telehealth
42 Years of Experience
Elite in Type 2 Diabetes (T2D)
Emory Medical Care Foundation Inc
80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Guillermo Umpierrez is an Endocrinologist in Atlanta, Georgia. Dr. Umpierrez has been practicing medicine for over 42 years and is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Diabetic Ketoacidosis, Low Blood Sugar, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

His clinical research consists of co-authoring 332 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 162 articles and participated in 5 clinical trials in the study of Type 2 Diabetes (T2D).

Specialties
Endocrinology
Licenses
Internal Medicine in GA
Hospital Affiliations
Grady Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

EMORY MEDICAL CARE FOUNDATION INC
80 Jesse Hill Jr Dr Se, Atlanta, GA 30303

Additional Areas of Focus

Dr. Umpierrez has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Emory Latino Diabetes Education Program
Emory Latino Diabetes Education Program
Enrollment Status: Suspended
Publish Date: November 18, 2024
Time in Glucose Hospital Target (TIGHT) - A Randomized Clinical Trial to Evaluate the Use of CGM to Achieve a Mean Glucose Target of 90 to 130 mg/dL Without Hypoglycemia in Hospitalized Adults With Type 2 Diabetes
Time in Glucose Hospital Target (TIGHT) - A Randomized Clinical Trial to Evaluate the Use of CGM to Achieve a Mean Glucose Target of 90 to 130 mg/dL Without Hypoglycemia in Hospitalized Adults With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: March 22, 2024
Intervention Type: Device
Study Phase: Not Applicable
PERL (Preventing Early Renal Loss in Diabetes) Continuous Glucose Monitoring (CGM) Study
PERL (Preventing Early Renal Loss in Diabetes) Continuous Glucose Monitoring (CGM) Study
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Other, Drug
A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide Versus Glargine Insulin for the Management of Patients With Type 2 Diabetes After Hospital Discharge
A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide Versus Glargine Insulin for the Management of Patients With Type 2 Diabetes After Hospital Discharge
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 4
Inpatient and Post-hospital Discharge Assessment of Glycemic Control by Capillary Point-of-care Glucose Testing and by Continuous Glucose Monitoring in Insulin-treated Patients With Type 1 and Type 2 Diabetes: Dexcom G6 Observational Study
Inpatient and Post-hospital Discharge Assessment of Glycemic Control by Capillary Point-of-care Glucose Testing and by Continuous Glucose Monitoring in Insulin-treated Patients With Type 1 and Type 2 Diabetes: Dexcom G6 Observational Study
Enrollment Status: Completed
Publish Date: August 05, 2021
Intervention Type: Diagnostic test, Device
Study Phase: Not Applicable
Fixed Rate Continuous Subcutaneous Glucagon Infusion (CSGI) vs Placebo in Type 1 Diabetes Mellitus Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses to Insulin-Induced Hypoglycemia
Fixed Rate Continuous Subcutaneous Glucagon Infusion (CSGI) vs Placebo in Type 1 Diabetes Mellitus Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses to Insulin-Induced Hypoglycemia
Enrollment Status: Terminated
Publish Date: February 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Linagliptin Inpatient Trial: A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin (Tradjenta®) Therapy for the Inpatient Management of General Surgery Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 20, 2019
Intervention Type: Drug
Study Phase: Phase 4
A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Long-Term Care Residents With Type 2 Diabetes
A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Long-Term Care Residents With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: August 22, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

332 Total Publications

A randomized controlled trial of patient navigators for post-hospital discharge diabetic foot ulcer care: the Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-Foot-Nav) study protocol.
A randomized controlled trial of patient navigators for post-hospital discharge diabetic foot ulcer care: the Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-Foot-Nav) study protocol.
Journal: medRxiv : the preprint server for health sciences
Published: December 08, 2025
Similar Doctors
Bruce W. Bode
Elite in Type 2 Diabetes (T2D)
Dr. Bruce W. Bode
Internal Medicine | Endocrinology
Elite in Type 2 Diabetes (T2D)
Dr. Bruce W. Bode
Internal Medicine | Endocrinology

Atlanta Diabetes Associates

1800 Howell Mill Road, Suite 450, 
Atlanta, GA 
 (4.1 miles away)
404-355-4393
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bruce Bode is an Internal Medicine specialist and an Endocrinologist in Atlanta, Georgia. Dr. Bode is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Bode is currently accepting new patients.

Elite in Type 2 Diabetes (T2D)
Dr. Maya Fayfman
Endocrinology
Elite in Type 2 Diabetes (T2D)
Dr. Maya Fayfman
Endocrinology

Emory Medical Care Foundation Inc

80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
 (0.1 miles away)
404-616-1000
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Maya Fayfman is an Endocrinologist in Atlanta, Georgia. Dr. Fayfman has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Ketoacidosis, Low Blood Sugar, and Maturity Onset Diabetes of the Young.

Distinguished in Type 2 Diabetes (T2D)
Dr. Priyathama Vellanki
Endocrinology
Distinguished in Type 2 Diabetes (T2D)
Dr. Priyathama Vellanki
Endocrinology

Emory Medical Care Foundation Inc

80 Jesse Hill Jr Dr Se, 
Atlanta, GA 
 (0.1 miles away)
404-616-1000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Priyathama Vellanki is an Endocrinologist in Atlanta, Georgia. Dr. Vellanki is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). Her top areas of expertise are Diabetic Ketoacidosis, Low Blood Sugar, Type 2 Diabetes (T2D), End-Stage Renal Disease (ESRD), and Coronary Artery Bypass Graft (CABG).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Umpierrez's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile